DR LAL PATHLABS Financial Statement Analysis
|
||
|
The Revenues of DR LAL PATHLABS have increased by 32.01% YoY .
The Earnings Per Share (EPS) of DR LAL PATHLABS has decreased by -30.75 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
DR LAL PATHLABS Last 5 Annual Financial Results
[BOM: 539524|NSE : LALPATHLAB]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Operating Income | ₹2,087 Cr | ₹1,581 Cr | ₹1,330 Cr | ₹1,203 Cr | ₹1,057 Cr |
| Expenses | ₹1,527 Cr | ₹1,145 Cr | ₹987 Cr | ₹910 Cr | ₹793 Cr |
| Operating Profit (Excl OI) | ₹561 Cr | ₹436 Cr | ₹344 Cr | ₹294 Cr | ₹264 Cr |
| Other Income | ₹53 Cr | ₹51 Cr | ₹55 Cr | ₹46 Cr | ₹31 Cr |
| Interest | ₹30 Cr | ₹16 Cr | ₹15 Cr | ₹0.84 Cr | ₹0.84 Cr |
| Depreciation | ₹108 Cr | ₹77 Cr | ₹73 Cr | ₹38 Cr | ₹33 Cr |
| Profit Before Tax | ₹475 Cr | ₹394 Cr | ₹311 Cr | ₹301 Cr | ₹261 Cr |
| Profit After Tax | ₹350 Cr | ₹296 Cr | ₹228 Cr | ₹200 Cr | ₹172 Cr |
| Consolidated Net Profit | ₹345 Cr | ₹292 Cr | ₹226 Cr | ₹199 Cr | ₹171 Cr |
| Earnings Per Share (Rs) | ₹28.65 | ₹41.37 | ₹34.99 | ₹27.11 | ₹23.90 |
| PAT Margin (%) | 11.95 | 16.78 | 18.75 | 17.11 | 16.66 |
| ROE(%) | 15.80 | 26.45 | 26.89 | 23.74 | 23.76 |
| ROCE(%) | 20.34 | 32.67 | 36.03 | 32.94 | 34.78 |
| Total Debt/Equity(x) | 0.15 | 0.24 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 19,463.9 Cr |
| Revenue (TTM) | : | ₹ 2,172.2 Cr |
| Net Profit(TTM) | : | ₹ 333.4 Cr |
| EPS (TTM) | : | ₹ 39.9 |
| P/E (TTM) | : | 58.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DR LAL PATHLABS | 12.9% | -7.3% | 19.6% |
| APOLLO HOSPITALS ENTERPRISE | 3.4% | -6.6% | 49% |
| MAX HEALTHCARE INSTITUTE | 5.7% | -8.7% | 59.1% |
| GLOBAL HEALTH | 6.7% | -13.1% | 164.4% |
| FORTIS HEALTHCARE | 2.6% | -6.4% | 59.4% |
| NARAYANA HRUDAYALAYA | 2% | -9.6% | 59.5% |
| ASTER DM HEALTHCARE | 1.9% | -6.1% | 86.2% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 3.3% | -8.3% | 51.4% |
| RAINBOW CHILDRENS MEDICARE | 6.7% | -2% | 68.5% |
DR LAL PATHLABS Revenues
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 32.01 % |
| 5 Yr CAGR | 18.55 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | 18.86 | |
| Mar2021 | ₹1,330 Cr | 10.55 | |
| Mar2020 | ₹1,203 Cr | 13.86 | |
| Mar2019 | ₹1,057 Cr | - | |
DR LAL PATHLABS Operating Profit
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 28.52 % |
| 5 Yr CAGR | 20.72 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹561 Cr | 28.52 | |
| Mar2022 | ₹436 Cr | 26.98 | |
| Mar2021 | ₹344 Cr | 17.00 | |
| Mar2020 | ₹294 Cr | 11.24 | |
| Mar2019 | ₹264 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -2.65 % |
| 5 Yr CAGR | 1.83 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 26.86% | -2.65 | |
| Mar2022 | 27.59% | 6.81 | |
| Mar2021 | 25.83% | 5.86 | |
| Mar2020 | 24.4% | -2.32 | |
| Mar2019 | 24.98% | - | |
DR LAL PATHLABS Profit After Tax
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 18.25 % |
| 5 Yr CAGR | 19.21 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | 29.07 | |
| Mar2021 | ₹226 Cr | 13.44 | |
| Mar2020 | ₹199 Cr | 16.66 | |
| Mar2019 | ₹171 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -28.78 % |
| 5 Yr CAGR | -7.97 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 11.95 % | -28.78 | |
| Mar2022 | 16.78 % | -10.51 | |
| Mar2021 | 18.75 % | 9.59 | |
| Mar2020 | 17.11 % | 2.70 | |
| Mar2019 | 16.66 % | - | |
DR LAL PATHLABS Earnings Per Share (EPS)
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | -30.75 % |
| 5 Yr CAGR | 4.64 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹29 | -30.75 | |
| Mar2022 | ₹41 | 18.23 | |
| Mar2021 | ₹35 | 29.07 | |
| Mar2020 | ₹27 | 13.43 | |
| Mar2019 | ₹24 | - | |
DR LAL PATHLABS Return on Capital Employed (ROCE)
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | -37.74 % |
| 5 Yr CAGR | -12.55 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 20.34% | -37.74 | |
| Mar2022 | 32.67% | -9.33 | |
| Mar2021 | 36.03% | 9.38 | |
| Mar2020 | 32.94% | -5.29 | |
| Mar2019 | 34.78% | - | |
DR LAL PATHLABS Share Price vs Sensex
| Current Share Price | : | ₹2,331.0 |
| Current MarketCap | : | ₹ 19,463.9 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 12.9% |
-7.3% |
19.6% |
| SENSEX | 1.3% |
2.6% |
24% |
DR LAL PATHLABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
| S&P BSE 150 MIDCAP | 1.6% | 8.5% | 56.7% |
| S&P BSE SMALLCAP SELECT INDEX | 1.6% | 10.1% | 46% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MID SMALL400 | 2.1% | 10.7% | 62.3% |
| NIFTY500 MULTICAP 50:25:25 | 1.8% | 7.7% | 48.1% |
| NIFTY MIDCAP150 | 1.7% | 9.1% | 57.8% |
| NIFTY FREE MIDCAP 100 | 1.5% | 8.9% | 60.2% |
| NIFTY 500 | 1.5% | 5.7% | 39.5% |
You may also like the below Video Courses
FAQ about DR LAL PATHLABS Financials
How the annual revenues of DR LAL PATHLABS have changed ?
The Revenues of DR LAL PATHLABS have increased by 32.01% YoY .
How the Earnings per Share (EPS) of DR LAL PATHLABS have changed?
The Earnings Per Share (EPS) of DR LAL PATHLABS has decreased by -30.75 % YoY .
Check out Intrinsic Value of Peers of DR LAL PATHLABS
Compare Stock Analytics of Peers of DR LAL PATHLABS
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
